Publikationen, an denen er mitarbeitet Sainza García Fernández (12)

2021

  1. Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder

    Translational Psychiatry, Vol. 11, Núm. 1

  2. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Functionality and Neurocognition in Patients With Bipolar Disorder After a Physical-Exercise Program (FINEXT-BD Study): Protocol of a Randomized Interventionist Program

    Frontiers in Psychiatry, Vol. 11

2019

  1. Association between medication adherence and oxidative stress in patients with first-episode mania

    Frontiers in Psychiatry, Vol. 10, Núm. MAR

  2. Neutrophil count is associated with reduced gray matter and enlarged ventricles in first-episode psychosis

    Schizophrenia Bulletin, Vol. 45, Núm. 4, pp. 846-858

2018

  1. Affective versus first-episode non-affective first-episode psychoses: A longitudinal study

    Journal of Affective Disorders, Vol. 238, pp. 297-304

  2. Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 5, pp. 441-455

  3. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 2, pp. 145-154

  4. Overdosing of benzodiazepines/Z-drugs and falls in older adults: Costs for the health system

    Experimental Gerontology, Vol. 110, pp. 42-45

  5. The complex association between the antioxidant defense system and clinical status in early psychosis

    PLoS ONE, Vol. 13, Núm. 4

  6. Therapeutic Drug Monitoring of Second-Generation Antipsychotics for the Estimation of Early Drug Effect in First-Episode Psychosis: A Cross-sectional Assessment

    Therapeutic Drug Monitoring, Vol. 40, Núm. 2, pp. 257-267

2016

  1. Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients

    Journal of Clinical Psychopharmacology, Vol. 36, Núm. 4, pp. 355-371